Pfizer Inc. Seeks 10-fold Rise in Global Cancer-Drug Sales by 2018

July 13 (Bloomberg) -- Pfizer Inc. plans for its worldwide sales of medicines for treating cancer to increase 10-fold by 2018, said Andreas Penk, regional president of the company’s cancer business in Europe.

MORE ON THIS TOPIC